P1:OSO/OVY P2:OSO/OVY QC:OSO/OVY T1:OSO LWBK1211-Standard-FM LWBK1211-Domino March9,2013 11:53 The 5-Minute Clinical Consult 220134 22ND EDITION i P1:OSO/OVY P2:OSO/OVY QC:OSO/OVY T1:OSO LWBK1211-Standard-FM LWBK1211-Domino March9,2013 11:53 ADVISORY BOARD David Drajpuch, MSN, CRNP Faculty,FamilyHealthNursePractitioner FAMILY MEDICINE Program UniversityofPennsylvaniaSchoolofNursing Jonathan Bertman, MD NursePractitioner,Cardiology ClinicalAssistantProfessorofFamilyMedicine Children’s HospitalofPhiladelphia TheAlpertMedicalSchoolofBrownUniversity Philadelphia,Pennsylvania President,AmazingChart.com,Inc. President,AfraidToAsk.com,Inc. June Treston, MSN, CRNP HopeValley,RhodeIsland AssociateProgramDirector Karen L. Maughan, MD FamilyHealthNursePractitionerProgram UniversityofPennsylvaniaSchoolofNursing AssociateProfessorofFamilyMedicine Philadelphia,Pennsylvania DepartmentofFamilyMedicine NursePractitioner,EmergencyMedicine UniversityofVirginia CooperUniversityMedicalCenter Charlottesville,Virginia Camden,NewJersey INTERNAL MEDICINE Rebecca M. Wolf, BSN, RN, MSN, FNP Eric J. Alper, MD MayoClinic ProfessorofMedicine Rochester,Minnesota MedicalDirector,InpatientEMR UMassMedicalSchool/UMassMemorialHealthCare PHARMACY Worcester,Massachusetts Michele L. Matthews, PharmD, CPE, BCACP Erik Garcia, MD AssistantProfessorofPharmacyPractice AssistantProfessor MassachusettsCollegeofPharmacyandHealth DepartmentofFamilyMedicineandCommunityHealth SciencesUniversity UniversityofMassachusettsMedicalSchool ClinicalPharmacySpecialistinPainManagement Worcester,Massachusetts BrighamandWomen’s Hospital Nancy Kubiak, MD Boston,Massachusetts AssociateProfessor InternalMedicine PHYSICIAN ASSISTANT UniversityofLouisville Louisville,Kentucky Nancy McLaughlin, MPAS, PA-C ClinicalAssistantProfessor NURSE PRACTITIONERS CollegeofPharmacyandHealthSciences PhysicianAssistantProgram Eileen F. Campbell, MSN, CRNP MercerUniversity AssociateProgramDirector Atlanta,Georgia FamilyHealthNursePractitionerProgram UniversityofPennsylvania Philadelphia,Pennsylvania FamilyNursePractitioner DirectorofClinicalResearch AdvocareHeightsPrimaryCare HaddonHeights,NewJersey ii P1:OSO/OVY P2:OSO/OVY QC:OSO/OVY T1:OSO LWBK1211-Standard-FM LWBK1211-Domino March9,2013 11:53 The 5-Minute Clinical Consult 220134 Editor-in-Chief FrankJ.Domino,MD Professor Pre-doctoralEducationDirector DepartmentofFamilyMedicineandCommunityHealth TheUniversityofMassachusettsMedicalSchool Worcester,Massachusetts 22ND EDITION Associate Editors RobertA.Baldor,MD Professor Vice-Chairman DepartmentofFamilyMedicineandCommunityHealth TheUniversityofMassachusettsMedicalSchool Worcester,Massachusetts JeremyGolding,MD Professor DepartmentsofFamilyMedicineandObstetrics andGynecology TheUniversityofMassachusettsMedicalSchool QualityOfficer DepartmentofFamilyMedicineandCommunityHealth UniversityofMassachusettsMemorialHealthCare– HahnemannFamilyHealthCenter Worcester,Massachusetts JillA.Grimes,MD,FAAFP ClinicalInstructor DepartmentofFamilyMedicine TheUniversityofMassachusettsMedicalSchool Worcester,Massachusetts UniversityofTexasHealthServices Austin,Texas iii P1:OSO/OVY P2:OSO/OVY QC:OSO/OVY T1:OSO LWBK1211-Standard-FM LWBK1211-Domino March9,2013 11:53 AcquisitionsEditor:SonyaSeigafuse/RebeccaGaertner ProductManager:KerryBarrett/LeanneVandetty ProductionProjectManager:PriscillaCrater SeniorManufacturingManager:BenjaminRivera MarketingManager:KimberlySchonberger DesignCoordinator:TeresaMallon ProductionService:Aptara,Inc. (cid:2)C 2014byLIPPINCOTTWILLIAMS&WILKINS,aWOLTERSKLUWERbusiness TwoCommerceSquare 2001MarketStreet Philadelphia,PA19103USA LWW.com Allrightsreserved.Thisbookisprotectedbycopyright.Nopartofthisbookmaybereproducedinanyform byanymeans,includingphotocopying,orutilizedbyanyinformationstorageandretrievalsystemwithout writtenpermissionfromthecopyrightowner,exceptforbriefquotationsembodiedincriticalarticlesand reviews.MaterialsappearinginthisbookpreparedbyindividualsaspartoftheirofficialdutiesasU.S. governmentemployeesarenotcoveredbytheabove-mentionedcopyright. PrintedinChina LibraryofCongressCataloging-in-PublicationData ISBN-13:978-1-4511-8850-9 ISBN-10:1-4511-8850-1 Carehasbeentakentoconfirmtheaccuracyoftheinformationpresentedandtodescribegenerally acceptedpractices.However,theauthors,editors,andpublisherarenotresponsibleforerrorsoromissions orforanyconsequencesfromapplicationoftheinformationinthisbookandmakenowarranty,expressed orimplied,withrespecttothecurrency,completeness,oraccuracyofthecontentsofthepublication. Applicationoftheinformationinaparticularsituationremainstheprofessionalresponsibilityofthe practitioner. Theauthors,editors,andpublisherhaveexertedeveryefforttoensurethatdrugselectionanddosage setforthinthistextareinaccordancewithcurrentrecommendationsandpracticeatthetimeofpublication. However,inviewofongoingresearch,changesingovernmentregulations,andtheconstantflowof informationrelatingtodrugtherapyanddrugreactions,thereaderisurgedtocheckthepackageinsertfor eachdrugforanychangeinindicationsanddosageandforaddedwarningsandprecautions.Thisis particularlyimportantwhentherecommendedagentisaneworinfrequentlyemployeddrug. SomedrugsandmedicaldevicespresentedinthepublicationhaveFoodandDrugAdministration(FDA) clearanceforlimiteduseinrestrictedresearchsettings.Itistheresponsibilityofthehealthcareproviderto ascertaintheFDAstatusofeachdrugordeviceplannedforuseintheirclinicalpractice. Topurchaseadditionalcopiesofthisbook,callourcustomerservicedepartmentat(800)638-3030orfax ordersto(301)223-2320.Internationalcustomersshouldcall(301)223-2300. VisitLippincottWilliams&WilkinsontheInternet:atLWW.com.LippincottWilliams&Wilkinscustomer servicerepresentativesareavailablefrom8:30amto6pm,EST. 10 9 8 7 6 5 4 3 2 1 iv P1:OSO/OVY P2:OSO/OVY QC:OSO/OVY T1:OSO LWBK1211-Standard-FM LWBK1211-Domino March9,2013 11:53 My good friend and mentor, Sanjiv Chopra, tells the story of Charlie Plumb, a Vietnam War pilot who was shot down, parachuted, and became a prisoner of war. Later in life, he met and thanked the person who “packed his parachute.’’ Many people have given us support and guidance, helped us in ways we could never have foreseen would result in our current careers. This year’s editorial team wishes to dedicate The 5-Minute Clinical Consult 2014 to these people; those who spurred us on long before there were degrees and titles gracing our names. Thank you for packing our parachutes. “Anything worth doing is worth doing right!’’ This phrase was my mother’s mantra, frequently uttered as she calmly ripped out one of my imperfect, hastily sewn seams, and then smoothly ironed, pinned, and restitched the piece. Whether it was domestic crafts, school homework, or volunteer projects, I heard these words each time I approached that critical frustration point where I was about to quit caring about quality and simply finish as quickly as possible. Although my mom is no longer around to remind me in person, her message remains etched in my heart and drives my actions, especially as a clinician. Follow up on that slightly abnormal lab. Ask your patient about her nutrition. Take that extra 5 minutes, and look up the latest evidence-based diagnostic tests or treatment. Anything worth doing is, indeed, worth doing right. Thanks, Mom! –JILLGRIMES,MD,FAAFP My vision of becoming a family doctor was almost obscured by so many subspecialty mists in medical school.Fortunately,IfoundguideswhoselightsIfollowed,andwhotaughtmetolightmyownlamp.Iowea permanentdebttoJackMedalie,MD,andthefacultyofthefamilymedicinecenteratCaseWesternReserve Medical School in the mid-80s. They and my mentors and role models in residency and fellowship at the University of Rochester/Highland Hospital Family Medicine residency taught me to think critically, to listen carefully to what patients were saying, and also to what they were not saying. These lessons helped me comeintomyownasafamilydoctor,anditisintheirnamesthatIsharewhatIknowwithmystudentsnow. –JEREMYGOLDING,MD David Seeley was my high school AP biology teacher. He challenged my class to reach beyond what we ever thought we were capable of—an example was the time I received a grade on a lab assignment that was less than zero! I was stunned. I was convinced I was the best student in that class and although I may have been, it was clear I could always do better. Such a grade brought me to a new level of thinking about achievement (and humility!). I have carried this and other such lessons from this great teacher with me throughout my education and career. Although Mr. Seeley passed away a few years ago, his legacy lives on through the profound impact he had on the lives of many young people in Barre, Vermont. –ROBERTBALDOR,MD Mary Grosso smoked, gave me my first taste of beer, used a colorful vocabulary, and taught me to play poker; in her view, a grandmother’s role. In my youth, I was shy and easily intimidated. Mary helped start a textiles workers union and was, to my young brain, someone who did not let the constraints of the day hold her back. My mom and dad’s love and support, my brother’s guidance and mentoring, and the other Mary in my life (who helped teach me to cook; still one of my favorite hobbies) all developed my character. But, my path to medicine came with challenges that took a great deal of determination to get past. Many taughtmescience;Marytaughtmeself-confidence,tonotlettheconstraintsofthedayholdmeback.Her determination helped many who followed live better lives; a legacy all of us in health care strive to provide. –FRANKJ.DOMINO,MD v P1:OSO/OVY P2:OSO/OVY QC:OSO/OVY T1:OSO LWBK1211-Standard-FM LWBK1211-Domino March9,2013 11:53 vi P1:OSO/OVY P2:OSO/OVY QC:OSO/OVY T1:OSO LWBK1211-Standard-FM LWBK1211-Domino March9,2013 11:53 PREFACE (cid:2) “Successisnotthekeytohappiness; FREEPointofCareCME:1/2hourCMECreditforeverydigital Happinessisthekeytosuccess. search Ifyoulovewhatyouaredoing,youwillbesuccessful.’’ (cid:2)200+diagnosticandtreatmentalgorithms (cid:2) Full-colorimagesandvideosforproceduresandtreatment —ALBERTSCHWEITZER (cid:2) DrugdatabasefromAtoZ Iam the most fortunate person I know. Even as a salaried aca- (cid:2)Morethan1,300patienthandoutsinEnglishandSpanish demicfamilydoctor,Ireceivemorefinancialincomethan95% (cid:2) ICD-10Codes(Websiteonlyforthisyear;inboth,printand ofthepeopleintheworld.Additionally,Ihavetheesteemofmy online,startingin2014,whenICD-10becomesmandatory) otherspecialtypeersinmedicine,theincrediblerelationshipswith mypatients,andtheintellectualfuninbeingchallengedeachday Evidence-basedhealthcareistheintegrationofthebestmedical toblendsciencewithinterpersonalcommunicationtohelpothers informationwiththevaluesofthepatientandyourskillasaclinician. livetheirdaysinabetterway. WehaveupdatedourEBMcontentanditsvisibility,soyoucanfocus AlbertSchweitzerwasatheologian,musician,imprisonedmis- onhowtobestapply. sionary,philosopher,andphysician.Incrediblyintelligentandinsight- TheHealthMaintenance1-pagesummarieshavebeenupdated ful,heusedhisgiftstomaketheworldabetterplace.Istandinawe throughDecember2012andarebasedontheUSPreventiveSer- andamhumbled.So,wheneverIgetdiscouragedbythenextform vicesTaskForcerecommendations. tocompleteorcodetoenter,IneedtorememberhowfortunateI The Algorithm section includes both diagnostic and treatment am,and,likeSchweitzer,Igettousemygiftstohelpothers.Like algorithms.Thiseasy-to-usegraphicmethodhelpsyouevaluatean Isaid,we,ashealthcareproviders,arelucky,andinSchweitzer’s abnormal finding and prioritize treatment. They are also excellent view,happyand,therefore,successful. teachingtools,sosharethemwiththelearnersinyouroffice. WelcometoThe5-MinuteClinicalConsult2014.Oureditorial Pleasetrytheonlineandmobileversionsatwww.5minuteconsult. teamhasagaincollaboratedwithhundredsofauthorstobringyou com.Your30-dayaccessisfreewithbookpurchase(seeinside this comprehensive and current resource whose goal is to assist the front cover), allowing you to quickly reference the 5-Minute youandyourpatients. whereverneeded.Includedareover900topicsonaneasy-to-use Thishighlyorganizedcontent,bothinprintandonline,provides interface allowing smooth maneuverability between topics, algo- youwith: rithms,images,videoprocedures,andmore,aswellasextratopics (cid:2) notinthebook. Fast,intuitivesearchfunctionalityprovidingyouwithanswersin <30seconds Welcome to The 5-Minute Clinical Consult 2014. Our edito- (cid:2) rial team values your observations, so please drop me an e-mail Currentevidence-baseddesignationshighlightedineachtopic’s andshareyourthoughts,suggestions,andconstructivecriticismat: text (cid:2) [email protected]. ArevisedandupdatedHealthMaintenancesection (cid:2)Morethan900topics FRANKJ.DOMINO,MD January1,2013 vii P1:OSO/OVY P2:OSO/OVY QC:OSO/OVY T1:OSO LWBK1211-Standard-FM LWBK1211-Domino March9,2013 11:53 viii P1:OSO/OVY P2:OSO/OVY QC:OSO/OVY T1:OSO LWBK1211-Standard-FM LWBK1211-Domino March9,2013 11:53 EVIDENCE-BASED MEDICINE WHATISEVIDENCE-BASEDMEDICINE? Positivepredictivevalue(PPV):Percentofpositivetest resultsthataretrulypositive;thePPVforawomanaged50–59 Rememberwhenweusedtotreateveryotitismediawithan- isapproximately22%.Thatistosaythatonly22%ofabnormal tibiotics?Theserecommendationscameaboutbecausewe screeningmammogramsinthisgrouptrulyidentifiedcancer.The appliedlogicalreasoningtoobservationalstudies.Ifbacteria other78%arefalsepositives. causeanacuteotitismedia,thenantibioticsshouldhelpitresolve YoucantellMLonly1outof5abnormalmammogramscorrectly sooner,withlessmorbidity.Yet,whenrigorouslystudied(viaasys- identifycancer;the4arefalsepositives,buttheonlywaytoknow tematicreview),wefoundlittlebenefittothisintervention. whichmammogramiscorrectistodofurthertesting. The underlying premise of evidence-based medicine (EBM) is The corollary of the PPV is the Negative predictive theevaluationofmedicalinterventions,andtheliteraturethatsup- value(NPV),whichisthepercentofnegativetestresultsthat ports those interventions, in a systematic fashion. EBM hopes to aretrulynegative. encouragetreatmentsproventobeeffectiveandsafe.Andwhen The PPV and NPV tests are population dependent, while the insufficient data exists, it hopes to inform you on how to safely SensitivityandSpecificityarecharacteristicsofthetest,andhave proceed. little to do with the patient in front of you. So when you receive EBMusesasendpointsofrealpatientoutcomes;morbidity,mor- anabnormallabresult,especiallyascreeningtestlikemammogra- talityandrisk.Itfocuseslessonintermediateoutcomes(boneden- phyorPSAvalue,understandtheirlimitsbasedontheirPPVand sity)andmoreonpatientconditions(hipfractures). NPV. Implementing EBM requires 3 components: The best medical TreatmentInformationisalittledifferent.Indiscerning evidence,theskillandexperienceoftheprovider,andthevaluesof the statistics of randomized, controlled trials of interventions, thepatients.Shouldthispatientbescreenedforprostatecancer? firstconsideranexample.TheScandinavianSimvastatinSurvival Itdependsonwhatisknownaboutthetest,onwhatyouknowof Study(4S)(Lancet.1994;344[8934]:1383–1389)foundusing itsbenefitsandharms,yourabilitytocommunicatethatinformation, simvastatininpatientsathighriskforheartdiseasefor5years andthatpatient’sinformedchoice. resultedindeathsin8%ofpatientsvs.12%ofthoseonplacebo; ThisbookhopestoaddressthefirstEBMcomponent,providing this results in a relative risk of 0.70, a relative risk reduction you access the best information in a quick format. While not ev- (RRR)of33%,andanumberneededtotreatof25. erytestortreatmenthasthislevelofdetail,manyoftheincluded interventionshereusesystematicreviewliteraturesupport. Therearetwowaysofconsideringthebenefitsofanintervention Thelanguageofmedicalstatisticsisusefultointerpretingthe withrespecttoagivenoutcome.Theabsoluteriskreduction(ARR) conceptsofEBM.Belowisalistoftheseterms,withexamplesto isthedifferenceinthepercentofpeoplewiththeconditionbefore helptaketheconfusionandmysteryoutoftheiruse. andaftertheintervention.Thus,iftheincidenceofMIwas12%for the placebo group and 8% for the simvastatin group, the ARR is Prevalence:Proportionofpeopleinapopulationwhohave 4%(12%−8%=4%). adisease(intheUS,0.3%(3in1,000)peopleovertheage50 TheRRRreflectstheimprovementintheoutcomeasapercent- havecoloncancer). age of the original rate and is commonly used to exaggerate the Incidence: How many new cases of a disease occur in a benefitofanintervention.Thus,iftheriskofMIwerereducedbysim- populationduringanintervaloftime;forexample,“theestimated vastatinfrom12%to8%,thentheRRRwouldbe33%(4%/12%= incidenceofcoloncancerintheUSis104,000in2005.’’ 33%);33%mayappearbetterthan4%,the4%thatreflectsthe Sensitivity(Sn):Percentofpeoplewithdiseasewhotest trueoutcome. positive;formammography,thesensitivityis71–96%. ARR is usually a better measure of clinical significance of an Specificity (Sp): Percent of people without disease who intervention. For instance, in one study, the treatment of mild hy- testnegative;formammography,thespecificityis94–97%. pertensionwasbeenshowntohaveaRRRof40%over5years NowsupposeyousawML,a53-year-oldwoman,foraHealth (40%fewerstrokesinthetreatedgroup).However,theARRwas Maintenance visit and ordered a screening mammogram and the only 1.3%. Because mild hypertension is not strongly associated reportdemonstratesanirregularareaofmicrocalcifications.Sheis withstrokes,aggressivetreatmentofmildhypertensionyieldsonly waitinginyourofficetoreceivehertestresults;whatcanyoutell asmallclinicalbenefit.Don’tconfuseRelativeRiskReductionwith her? RelativeRisk. Thesetestsrefertocharacteristicsofpeoplewhoareknownto Absolute (or attributable) risk (AR): The percent of havedisease(sensitivity)orthosethatareknownnottohavedisease peopleintheplaceboorinterventiongroupwhoreachanend (specificity). What you have is an abnormal test result. To better point; in the simvastatin study, the absolute risk of death was explainthisresulttoML,youneedtoknowthepositivepredictive 8%. value,tohelpusinterpretthetestresults. ix P1:OSO/OVY P2:OSO/OVY QC:OSO/OVY T1:OSO LWBK1211-Standard-FM LWBK1211-Domino March9,2013 11:53 x (cid:2) (cid:2) (cid:2) Evidence-Based Medicine Relativerisk(RR):Theriskofdiseaseofthosetreatedor Publication bias occurs when research is not published; exposedtosomeintervention(i.e.,simvastatin)dividedbythose thisisoftenwhenastudyfindsdatathatdoesnot supportan intheplacebogrouporwhowereuntreated. intervention. The motivation to publish information that “didn’t —IfRR<1.0,itreducesrisk—thesmallerthenumber,the work’’islow.Itisestimatedthatupto40%ofallmedicalresearch greatertheriskreduction. nevergetspublished.Sowhenyoureadofaninterventionthat —IfRR>1.0,itincreasestherisk—thegreaterthenumber, “works,’’ wonder if other studies were done that did not show thegreatertheriskincrease. benefitandwentunpublished. Relative risk reduction (RRR): The relative decrease in Comparatorbiasoccurswhenresearchcomparesanin- riskofanendpointcomparedtothepercentofthatendpoint terventiontoplacebo,whenplaceboisnotthestandardofcare. intheplacebogroup. Knowing a new antibiotic is more effective than placebo for Ifyouarestillconfused,justremembertheRRRisanoveresti- treating acute otitis media is not helpful if you typically use mationoftheactualeffect. amoxicillin. Why not release research comparing the new drug to the Number needed to treat (NNT): This is the number of standardofcare?Often,theresearchhasbeendone,andthe peoplewhoneedtobetreatedbyaninterventiontopreventone adverseoutcome.A“good’’NNTcanbealargenumber(>100) newdrugprovednobetter.Ifthisstudydoesnotgetpublished, youhaveanexampleofpublicationbias. ifriskofseriousoutcomeisgreat.Iftheriskofanoutcomeis notthatdangerous,thenlower(<25)NNTsarepreferred. Selection bias involves either using a tool that does not discriminate between populations selected or just reporting a TheNNTshouldbecomparedtoasimilarstatistic,theNumber justsubsetofstudyparticipantsfromastudy.Eitherwillresultin NeededtoHarm(NNH).Thisisthenumberofpeoplewhohaveto thedatabeingskewedbecauseitcanonlybeappliedtosmall begiventreatmentbeforeoneexcesssideeffectorharmoccurs. subsetofpeople. WhentheNNTiscomparedtotheNNH,youandthepatientcan Attrition bias and the concept of intention to treat. judge whether the benefit of the intervention is great enough to Attritionbiasiswhenresearchersdonotfullyacknowledgeand outweightheriskofharm. addresshowastudydealswithparticipantswhodonotadhere totheresearchprotocolordropoutcompletely.Intentiontotreat EVIDENCED-BASEDGRADING: analysishopestodiminishattritionbiasbystatisticallyconsider- To help you interpret diagnostic and treatment recommendations ingthenonadheringordroppedoutpatientsasunsuccessfully withinThe5-MinuteClinicalConsult,wehavegradedthebestin- benefitingfromtheintervention. formationwithinthetext,andhighlightedthiscontent. Commercial (funder) bias involves who paid for the re- An“A’’grademeansthereferenceisfromthehighest-qualityre- search being done, and do they have a vested interest in the source,likeasystematicreview.Asystematicreviewisasummary outcome.Despiteitssizeandscope,therecentJupiter trialon of the medical literature on a given topic that uses strict, explicit treatinglow-riskadultswithastatinhasbeencalledintoques- methods to perform a thorough search of the literature and then tion, as the company who funded the study makes the brand provides a critical appraisal of individual studies, concluding in a namedrugusedinthestudyandtheleadauthorispartowner recommendation.Themostprestigiouscollectionofsystematicre- oftheuniquetestemployedinthetrial.Thedatamaybeaccu- viewsisfromtheCochraneCollaboration(www.cochrane.org). rate,butuntilthisisstudiedbylessvestedinterests,somefeel A“B’’grademeansthedatareferencedcomesfromhigh-quality itsoutcomecannotbeclinicallyapplied. randomizedcontrolledtrialsperformedtominimizebiasintheirout- Have you been annoyed how one week you learn of a ran- come.Biasisanythingthatinterfereswiththetruth;inthemedical domized controlled trial that supports a treatment, to be followed literature,itisoftenunintentional,butitismuchmorecommonthan the next week with a contradictory article? Statisticians have fig- weappreciate.Inshort,alwaysassumesomedegreeofbiasexists ured out how to resolve this using something called a systematic inanyresearchendeavor. review. A“C’’ gradeimpliesthereferenceuseddoesnotmeettheAor Systematic reviews take all the literature on a topic, say Brequirements;theyareoftentreatmentsrecommendedbycon- usingantibioticstotreatotitismedia,andcombinesthedatato sensusgroups(liketheAmericanCancerSociety).Insomecases, determineifthesumofallthetrialstellsadifferentstorythan theymaybethestandardsofcare.Butimplicitinagroup’srecom- any single trial. The large number of participants in this type mendationisthebiasoftheauthororthegroupthatsupportsthe of research results in a much more statistically (and clinically) reference.Forexample,theAmericanUrologicalSociety’s recom- significantconclusionthananysinglepaper.Wantmore?Check mendationaroundscreeningforprostatecancermaybemotivated thisout:http://musculoskeletal.cochrane.org/what-systematic- by their need for funding rather than patient outcomes. Compare review. this to the recommendations of the US Preventive Services Task Ameta-analysisisaquantitativesystematicreview,anddemon- Force(www.ahrq.gov). stratesitoutcomesintheformofaforestplot.Thebottomlinewith interpretationofaforestplotislookforthediamondonthebottom. BIAS: IfitistoLEFToftheverticalline,itmeansriskofanoutcomewas Biasisanythingthatinterfereswiththetruth.Therearemanytypes reducedbytheintervention.IfitisfullytotheRIGHT,thenriskof ofbiasthatshouldbeconsideredbythepublishersofmedicalin- thatoutcomewasincreased.Andifthediamondtouchesthevertical formation.Belowdescribesanumberofbiastypesthatoftenaffect line,itmeanstherewasnostatisticalinfluenceoftheintervention ourcarewithoutusknowingitispresent: on the outcome. To understand these concepts better, here is a